Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaelle Angrand

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Developmental Biology|November 8, 2015
Ptbp1 and Exosc9 knockdowns trigger skin stability defects through different pathwaysMaud Noiret, Stéphanie Mottier, Gaelle Angrand, et al.
Microbial Cell (Graz, Austria)|September 16, 2017
A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthinessMaría José Lista, Rodrigo Prado Martins, Gaelle Angrand, et al.
Nucleic Acids Research|November 9, 2022
Type I arginine methyltransferases are intervention points to unveil the oncogenic Epstein-Barr virus to the immune systemGaelle Angrand, Alicia Quillévéré, Nadège Loaëc, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Developmental Biology|November 8, 2015
Ptbp1 and Exosc9 knockdowns trigger skin stability defects through different pathwaysMaud Noiret, Stéphanie Mottier, Gaelle Angrand, et al.
Microbial Cell (Graz, Austria)|September 16, 2017
A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthinessMaría José Lista, Rodrigo Prado Martins, Gaelle Angrand, et al.
Nucleic Acids Research|November 9, 2022
Type I arginine methyltransferases are intervention points to unveil the oncogenic Epstein-Barr virus to the immune systemGaelle Angrand, Alicia Quillévéré, Nadège Loaëc, et al.
Pageof 1